142
Participants
Start Date
January 17, 2024
Primary Completion Date
March 31, 2028
Study Completion Date
March 31, 2028
azacitidine
during run-in and extention phase: from Cycle 1 until relapse
Venetoclax
during run-in and extention phase: from Cycle 1 until relapse
Cobicistat
"during run-in phase: from cycle 2 until relapse~during extension phase: from cycle 1 until relapse"
NOT_YET_RECRUITING
NL-Amersfoort-MEANDERMC, Amersfoort
NOT_YET_RECRUITING
NL-Amsterdam-OLVG, Amsterdam
NOT_YET_RECRUITING
NL-Amsterdam-VUMC, Amsterdam
NOT_YET_RECRUITING
NL-Arnhem-RIJNSTATE, Arnhem
NOT_YET_RECRUITING
NL-Breda-AMPHIA, Breda
NOT_YET_RECRUITING
NL-Dordrecht-ASZ, Dordrecht
NOT_YET_RECRUITING
NL-Eindhoven-CATHARINA, Eindhoven
NOT_YET_RECRUITING
NL-Eindhoven-MAXIMAMC, Eindhoven
NOT_YET_RECRUITING
NL-Enschede-MST, Enschede
RECRUITING
NL-Groningen-UMCG, Groningen
NOT_YET_RECRUITING
NL-Leeuwarden-MCL, Leeuwarden
NOT_YET_RECRUITING
NL-Leiden-LUMC, Leiden
NOT_YET_RECRUITING
NL-Maastricht-MUMC, Maastricht
NOT_YET_RECRUITING
NL-Nieuwegein-ANTONIUS, Nieuwegein
NOT_YET_RECRUITING
NL-Nijmegen-CWZ, Nijmegen
NOT_YET_RECRUITING
NL-Rotterdam-ERASMUSMC, Rotterdam
NOT_YET_RECRUITING
NL-Den Haag-HAGA, The Hague
NOT_YET_RECRUITING
NL-Zwolle-ISALA, Zwolle
Stichting Hemato-Oncologie voor Volwassenen Nederland
OTHER